Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Yung S. Lie, PhD, is the president and CEO of the Damon Runyon Cancer Research Foundation.
Prestigious prize goes to researchers who identified B cells and T cells and others who invented the HER2 targeted cancer therapy Herceptin.
Biomarker was not linked to response rates in two studies of Keytruda for lung cancer.
Betting on basic science is leading to breakthroughs in immune checkpoint inhibitors, CAR-T, targeted therapies, cancer vaccines and more.
“Don’t eat me” proteins are “like invisibility cloaks for the cancer,” preventing white blood cells from detecting and devouring tum...
“There were so many things that were outside of my control, so I decided to focus on the things that I could do something about.”
NKTR-214 plus Opdivo has been granted an FDA breakthrough therapy designation for advanced melanoma.
New research suggests that inducing necroptosis in or around tumor cells can help the immune system rid the body of cancer cells.
An interview with Michael Kaplan, president and CEO of the Melanoma Research Alliance, about curing the deadliest skin cancer
For patients, the decision to move forward with adjuvant therapy isn’t as cut and dry as it may seem.
The 60-plus year-old drug, a mainstay of treatment for many cancers, acts as chemotherapy and immunotherapy at high doses, a study finds.
New research asks if an alternative dosing schedule can produce the same effects with fewer side effects.
Conclusions from four recent studies could open up potential strategies for boosting the effectiveness of cancer immunotherapies.
Treatment involves selecting, multiplying and reinfusing cancer-fighting immune cells.
Engineered T cells kept leukemia from returning in 12 high-risk patients.
Experts discuss rapid changes in cancer treatment and in the management of infections that can accompany these therapies.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.